Cefadroxil Use for Musculoskeletal Infections in an Academic Pediatric Hospital.

Child Humans Cefadroxil / therapeutic use Hospitals, Pediatric
cefadroxil osteomyelitis retrospective case series

Journal

Journal of the Pediatric Infectious Diseases Society
ISSN: 2048-7207
Titre abrégé: J Pediatric Infect Dis Soc
Pays: England
ID NLM: 101586049

Informations de publication

Date de publication:
28 Dec 2022
Historique:
received: 10 06 2022
accepted: 13 09 2022
pubmed: 17 9 2022
medline: 30 12 2022
entrez: 16 9 2022
Statut: ppublish

Résumé

Forty-nine of 52 (94.2%) children with musculoskeletal infection (MSKI) were successfully treated with cefadroxil dosed at 30 mg/kg/day over a 10-year time period. Two failures were associated with poor medication adherence. Our study suggests that treatment of MSKI with cefadroxil offers acceptable outcomes. Confirmation through clinical trials is appropriate.

Identifiants

DOI: 10.1093/jpids/piac104 PMID: 36112393
pubmed: 36112393
pii: 6702164
doi: 10.1093/jpids/piac104
doi:

Substances chimiques

Cefadroxil 280111G160

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

590-593

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Erin Weslander (E)

Department of Pharmacy, Northwestern Memorial Hospital, USA.

Holly Thomas (H)

Division of Pediatric Infectious Diseases, UPMC Children's Hospital of Pittsburgh, USA.

Ralph Jeune (R)

Department of Pharmacy, UPMC Children's Hospital of Pittsburgh, USA.

Michael Green (M)

Division of Pediatric Infectious Diseases, UPMC Children's Hospital of Pittsburgh, USA.

John V Williams (JV)

Division of Pediatric Infectious Diseases, UPMC Children's Hospital of Pittsburgh, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Cefadroxil Use for Musculoskeletal Infections...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cefadroxil Use for Musculoskeletal Infections...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Céphalosporines › Céfalexine › Céfadroxil › Cefadroxil Use for Musculoskeletal Infections...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Hôpitaux › Hôpitaux spécialisés › Hôpitaux pédiatriques › Cefadroxil Use for Musculoskeletal Infections...